Programme

The agenda for 2013 is currently being finalised: once complete you will be able to view it here.

Overview

    • 08:30 - 08:50
      • Registration and refreshments

      • 08:50 - 09:00
        • Chairman’s opening remarks

        • 09:00 - 09:30
        • Keynote presentation: Delving into CDISC standards in order to fully comprehend the requirements that will be mandatory

          • Providing an overview of the CDISC standards currently in use in order to be aware of all the requirements

          • Explaining the reasons behind guidelines becoming mandatory requirements in efforts to implement them fully

          • Examining how CDASH, SDTM and ADaM provide an end-to-end solution for the industry from the point of capture to submission to appreciate the need for these standards

          • Revising the timelines the industry will have to work with in order to ensure in time implementation

          • Outlining the consequences industry will face if on time implementation is not followed in order to appreciate the importance of compliance

        • 09:30 - 10:00
          • Speaker

            John Rodermund – Senior Director, Data Management, Forest Laboratories
          • Forest Laboratories

          Establishing the right metrics to be used from the data collected in order to judge performance and look for areas of improvement

          • Considering the importance of being able to use the data to determine the level of performance in order to have a successful clinical trial

          • Reviewing what data and in what way it can be used for this analysis in order to make the right choices of metrics

          • Determining the significance of being able to choose the right metrics in order to successfully analyze the data collected

          • Assessing potential ways the right metrics can be chosen for data analysis in order to identify the areas of improvement and move forward with the study

          • Outlining the importance of adjusting the metrics used for the analysis of data of different types of studies in order to choose the right ones

          • Exploring ways metrics can be used to assist for improvement identification to ensure delivery of high quality data through many crossfunctional groups

        • 10:00 - 10:30
          • Speaker

            Dave Stein – Senior Director, Product Management, Perceptive Informatics
          • Perceptive Informatics

          Keynote presentation: The eClinical Platform – Making order out of chaos

          • Understand how the best-of-breed approach to implementing clinical trial applications has led to technology chaos, a lack of workflow and a lack of interoperability

          • Assessing the effectiveness of current trends that promise to unify and simplify the eClinical ecosystem

          • Understanding why clinical technology providers are taking advantage of the Cloud and how biopharma and CRO users are benefitting

          • Exploring ways that biopharma companies are leveraging old and new tools in regards to Direct-to-Patient trials in efforts to achieve more

          • Explaining eClinical Platform and how it differs from integrated systems in efforts to consider the implications of moving from independent systems to a complete platform

        • 10:30 - 11:00
          • Morning refreshments and networking

          • 11:00 - 11:30
            • Speaker

              Jesse Kooker – Global Head of Data Management, Galderma
            • Galderma

            Identifying the challenges associated with data issues when working with a vendor during a clinical trial in order to determine the best resolution

            • Considering the amount of queries that might have to be dealt with during a study in order to appreciate the importance of dealing with them efficiently

            • Reviewing the process of setting up queries while reviewing the data in order to determine the right person to generate them

            • Appreciating the importance of choosing the right person to deal with a query in order to ensure that all the parties involved in the study are up to date

            • Assessing the significance of dealing with a query and updating the data in order to move forward with the clinical trial

            • Choosing the best procedure to follow while setting up a query in order to do it efficiently and effectively

            • Determining the right person who would be responsible to close the query in order to verify it and to ensure it has been dealt with properly

          • 11:30 - 12:00
            • Speaker

              Sheryn Bruso – Manager of Data Management, Mesoblast
            • Mesoblast

            Defining the procedures that should be followed in regards to data standards and input into the system in order to ensure the most efficient study start-up

            • Providing a general overview of the time taken to input the data into the system before the trial begins in order to appreciate the timelines and the importance of reducing those

            • Considering the challenges associated with a swift study start-up in regards to data input in efforts to identify the areas of a start-up that can be improved

            • Providing ways to think well in advance and ahead of the schedule in order to use data set-ups available and hence reduce the time taken for a study start-up

            • Determining the most efficient way to ensure vendors have received all the data specification needed in order to start a clinical trial

            • Outlining data standards that can be used from previous studies for a new one in order to start the trial more efficiently

            • Ensuring edit checks are in place in order to reduce the time taken for a study start-up

          • 12:00 - 12:30
            • Session reserved for a representative from Cytel

              Cytel presents a case study revealing new strategies in data management planning and handing technologies proven to streamline the submission process.

            • 12:30 - 14:00
              • Lunch and Networking

              • 14:00 - 14:30
                • Speaker

                  Elsie Mathews – Director,Global Data Operations, Bristol Myers Squibb
                • Bristol-Myers Squibb

                Outlining ePRO methods and the problems associated with them to determine the most efficient data recording system depending on the type of the trial

                • Revising the methods patients use to record data during a study without a visit in order to provide a brief overview

                • Considering the reasons behind the use of ePRO methods rather than patients visiting a physician in order to justify these methods

                • Examining the problems associated with the data collection when using self-recording systems in order to look for an improvement

                • Assessing the importance of the use of the self-recorded data during a study in order to decide whether the study can be carried forward without worrying about standardization of this data

                • Explaining the impact of self recording data systems have on data capture, both paper and electronic in order to assess the impact on data managers

                • Exploring the latest ePRO technologies to establish how those can be incorporated within your company

              • 14:30 - 15:00
                • Speaker

                  Anna Kravets – Director, External Partner Platform, Merck
                • Merck

                Considering the role of the user experience in the quality of clinical trial data in order to improve productivity and satisfaction

                • Appreciating the importance of user experience as an important variable in order to achieve better return on your investment

                • Learning on how to make it part of your process in order to successfully implement solutions, services and processes

              • 15:00 - 15:30
                • Speaker

                  Michael Walker – Manager, Strategic Client Relations, Liason Healthcare
                • Liaison Healthcare

                Promoting collaboration by leveraging technology in order to accelerate clinical research

                • Outlining pharmaceutical trends with the use of customer information and patient data for secondary use

                • Understanding cloud-based services in pharma: standardization yet consideration of researcher needs

                • Examining actual customer case studies for customer/partner portals, CRO integration and a unified health data exchange

                • Uncovering how competing pharmaceutical companies can share a common platform in order to cut incurring costs

                • Determining where Bid Data fits into better serving your customers

              • 15:30 - 16:00
                • Afternoon refreshments and networking

                • 16:00 - 16:30
                  • Speaker

                    Susan Howard – Assistant Director, Clinical Data Management, GlaxoSmithKline
                  • GlaxoSmithKline

                  Establishing the challenges associated with risk based monitoring in order to save resources

                  • Choosing the best way of working effectively with the CRA team in order to save time

                  • Determining the frequency of site visits in order to use time efficiently

                  • Finding the most efficient method to ensure the sites are aware of all the tasks that need to be done in order to provide the right training if needed

                  • Outlining the right elements from the data that need verification in order to be able to choose the right sites that need to be monitored

                  • Examining the best way to make use of the resources in order to save the resources

                  • Ensuring the data has been verified in accordance with the protocol to make sure there will be no need to re-record the verified data

                • 16:30 - 17:00
                  • Speaker

                    Tracey Newman – Senior Manager, Clinical Data Management, Otsuka America Pharmaceutical
                  • Otsuka America Pharmaceutical

                  Considering how risk based monitoring can be equated to risk based data cleaning in order to compare and contrast

                  • Defining risk based monitoring in order to establish the impact it has on data cleaning

                  • Assessing options available when risk based monitoring goes wrong

                  • The knot in the water hose effect

                • 17:00 - 17:10
                  • Chairman’s summation and close of day one

                previousnext